Drugs / Aceclidine
Aceclidine
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | VIZZ | — | 2025-07-31 | fda.gov ↗ |
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06270030 | Mar → Apr 2024 | presbyopia | Corxel Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05936489 | Jul → Oct 2023 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT05431543 | Aug → Dec 2022 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
| Phase 2 | NCT05294328 | May → Aug 2022 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT06045299 | Sep 2023 → Aug 2024 | presbyopia | Corxel Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT05728944 | Mar → Dec 2023 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
| Phase 3 | NCT05753189 | Feb 2023 → Feb 2024 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
| Phase 3 | NCT05656027 | Dec 2022 → Dec 2023 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03201562 Comparator | Apr 2017 → May 2018 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aceclidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05294328 ↗ |
| Known as | 3-quinuclidinol acetate (ester) | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | 3-quinuclidinol dl-form acetate (ester) | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | Aceclidina | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | Aceclidine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | Aceclidine hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | LNZ100 | “LNZ100 (Aceclidine) non-preserved ophthalmic solution” NCT05936489 ↗1“LNZ100- aceclidine ophthalmic solution” NCT05294328 ↗ |
| Known as | NSC-657843 | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Known as | NSC-758239 | ChEMBL registry synonym — accepted as the source's own label CHEMBL20835 ↗ |
| Modality | Small molecule | — CHEMBL20835 ↗ |
| Route | Other | “Aceclidine ophthalmic solution” NCT05294328 ↗ |